The idea is to use the understanding of the pathways that adiponectin uses to
kill myeloma cells to create a drug that would do the same thing.
Not exact matches
The researchers then tested the capacity of the modified
cells to
kill human multiple
myeloma cells in laboratory studies and an animal model.
The investigational treatment was combined with chemotherapy and an autologous stem
cell transplant — a new strategy designed to target and
kill the
cells that give rise to
myeloma cells.
The researchers grew the modified
cells in the lab to increase their numbers and then injected them into an animal model where they again
killed human
myeloma cells.
The researchers modified a type of human immune
cell — called T lymphocytes, or T
cells — to target a molecule called CS1, which is found on more than 95 percent of
myeloma cells, and to
kill the
cells.
The new immune system that grows from the donor stem
cells can recognize
myeloma cells as «foreign» and
kill them, which is known as the «graft - vs -
myeloma» effect.